Gerharz, EW;Gschwend, JE.Standing the test of time: long-term results of standard procedures in urology.World J Urol.2006.24.3.229-230

Maier, C;Vesovic, Z;Bachmann, N;Herkommer, K;Braun, AK;Surowy, HM;Assum, G;Paiss, T;Vogel, W.Germline mutations of the MSR1 gene in prostate cancer families from Germany..Hum Mutat.2006.27.1.98-102

Hesse, A;Straub, M.Rational evaluation of urinary stone disease..Urol Res.2006.34.2.126-30

Hebbring, SJ;Fredriksson, H;White, KA;Maier, C;Ewing, C;McDonnell, SK;Jacobsen, SJ;Cerhan, J;Schaid, DJ;Ikonen, T;Autio, V;Tammela, TL;Herkommer, K;Paiss, T;Vogel, W;Gielzak, M;Sauvageot, J;Schleutker, J;Cooney, KA;Isaacs, W;Thibodeau, SN.Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer..Cancer Epidemiol Biomarkers Prev.2006.15.5.935-8

Kuefer, R;Autenrieth, M;Herkommer, K;Blum, P;Merseburger, A;Hofer, M;Rinnab, L;Gschwend, J;Ringhoffer, M.[Translational research in renal cell cancer. Illustrated by the example of the vascular endothelial growth factor pathway].Urologe A.2006.45.3.328, 330-5

Schwaibold, HE;Sivalingam, S;May, F;Hartung, R.The value of a second transurethral resection for T1 bladder cancer..BJU Int.2006.97.6.1199-201

May, F;Hartung, R.Surgical atlas. Transurethral resection of the prostate..BJU Int.2006.98.4.921-34

Straub, M;Hautmann, RE.[Kein Titel angegeben].Urologe A.2006.45.11.1385-1386

Straub, M;Hautmann, RE.[Evidence-based pharmacological metaphylaxis of stone disease.].Urologe A.2006.45.11.1399-1405

Straub, M.[What kind of stone prevention for whom? : Risk-adjusted metaphylaxis following urinary stone disease.].Urologe A.2006.45.11.1387-1391